title: Treatment of benign prostatic hyperplasia.
authors.affiliation: Sociedade Brasileira de Urologia (SBU).
authors.forename: Ricardo Vita
authors.initials: RV
authors.lastname: Nunes
authors.affiliation: Sociedade Brasileira de Urologia (SBU).
authors.forename: João
authors.initials: J
authors.lastname: Manzano
authors.affiliation: Sociedade Brasileira de Urologia (SBU).
authors.forename: José Carlos
authors.initials: JC
authors.lastname: Truzzi
authors.affiliation: Sociedade Brasileira de Urologia (SBU).
authors.forename: Aguinaldo
authors.initials: A
authors.lastname: Nardi
authors.affiliation: Sociedade Brasileira de Urologia (SBU).
authors.forename: Antonio
authors.initials: A
authors.lastname: Silvinato
authors.affiliation: Associação Médica Brasileira (AMB).
authors.forename: Wanderley Marques
authors.initials: WM
authors.lastname: Bernardo
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D058667:Adrenergic beta-3 Receptor Agonists / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use; D008517:Phytotherapy; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D011788:Quality of Life
chemical_list: D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D058667:Adrenergic beta-3 Receptor Agonists; D018727:Muscarinic Antagonists; D058986:Phosphodiesterase 5 Inhibitors